R1 RCM (US:RCM)2023-03-10 13:47Financial Performance & Growth - R1 expects approximately $2.3 billion in revenue for 2023[12] - The company anticipates a revenue Compound Annual Growth Rate (CAGR) exceeding 15% from 2018 to 2023[12, 57] - R1 projects an Adjusted EBITDA margin of approximately 26-27% for 2023[20, 60] - The company forecasts Adjusted EBITDA between $595 million and $630 million for 2023[60] - R1's revenue grew from $869 million in 2018 to an estimated $2305 million in 2023, while Adjusted EBITDA increased from $57 million to $613 million during the same period[57] Market & Operational Highlights - R1 operates in a Total Addressable Market (TAM) of approximately $115 billion[12] - The company covers over $900 billion in Total Net Patient Revenue (NPR)[13, 48] - R1 automates over 150 million tasks annually[42, 48] - R1's intelligent automation offering has led to an approximate 15% reduction in Full-Time Equivalents (FTEs) for its clients[48] Market Dynamics - The external spend in the RCM market is expected to more than double by 2030, growing at a CAGR of 12% from approximately $32 billion in 2022 to $77 billion[36, 39]